Intelligence · Clinical Pipeline
Structure Therapeutics Pipeline
All ClinicalTrials.gov programs at Structure Therapeutics — phase, modality, and trial IDs.
- Programs
- 13
Quick answer
Structure Therapeutics has 13 clinical development programs indexed from ClinicalTrials.gov, including phase, modality, indication text, and linked NCT identifiers.
-
Aleniglipron
Structure Therapeutics
Obese
1 trial -
Aleniglipron or Placebo
Structure Therapeutics
Obesity, Overweight, or Chronic Weight Management
2 trials -
GPC-100
Structure Therapeutics
Multiple Myeloma
1 trial -
GSBR-1290
Structure Therapeutics
Overweight or Obesity
1 trial -
TG-0054
Structure Therapeutics
Multiple Myeloma
1 trial -
TG-0054 (2.24 mg/kg)
Structure Therapeutics
Multiple Myeloma
1 trial -
TG-0054 combined with G-CSF
Structure Therapeutics
Multiple Myeloma
1 trial -
aleniglipron or placebo
Structure Therapeutics
Obesity
1 trial -
A phase 1 study to assess the mass balance, pharmacokinetics, metabolism, and excretion of GSBR-1290, containing a microtracer dose of [14C] GSBR-1290, in healthy participants
Structure Therapeutics
Not applicable - Healthy volonteers
1 trial -
GSBR-1290
Structure Therapeutics
Healthy Volunteers
1 trial -
GSBR-1290 (Capsule/Tablet)
Structure Therapeutics
Healthy Volunteers
1 trial -
TG-0054
Structure Therapeutics
Healthy
1 trial -
carotid-femoral pulse-wave velocity
Structure Therapeutics
Covid19
1 trial
Frequently asked questions
How many pipeline programs does Structure Therapeutics have?
13 published programs are linked to this sponsor in our ClinicalTrials.gov index.
Is this the complete company pipeline?
This hub lists all published programs for the sponsor in our database. Partnered or out-licensed assets may appear under multiple companies.
Data attribution: Data sources · All pipeline programs